Scientific Online Resource System

International Bulletin of Otorhinolaryngology

Current Aspects of Sudden Sensorineural Hearing Loss

Iglika Stancheva

Abstract

Sudden sensorineural hearing loss (SSNHL) is defined as a sensorineural threshold shift of at least 30 dB across three contiguous frequencies developing within 72 hours. Its incidence is 5 to 27 per 100,000 per year and the cause remains unknown in 71 to 90% of patients. An identical clinical picture may, however, be produced by a vestibular schwannoma, an infarction in the territory of the anterior inferior cerebellar artery, autoimmune disease or intralabyrinthine haemorrhage. The condition is treated as an emergency because outcome depends on how soon treatment begins and because a serious disorder may lie behind it. This review summarises current data on aetiology, the diagnostic work-up and the recommendations of the AAO-HNSF (2019), the German, Japanese (2024) and European documents, together with current practice in Bulgaria, where no national guideline exists. A treatment algorithm covering both initial and salvage therapy is proposed.

Keywords

sudden sensorineural hearing loss; idiopathic sudden deafness; corticosteroids; intratympanic therapy; hyperbaric oxygenation; otological emergency.

Full Text


References

De Kleyn A. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol (Stockh), 1944, 32(5-6):407-429.

Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngol Head Neck Surg, 2019, 161(1_suppl):S1-S45.

Kitoh R, Nishio SY, Ogawa K, et al. Nationwide epidemiological survey of idiopathic sudden sensorineural hearing loss in Japan. Acta Otolaryngol, 2017, 137(sup565):S8-S16.

Schreiber BE, Agrup C, Haskard DO, Luxon LM. Sudden sensorineural hearing loss. Lancet, 2010, 375(9721):1203-1211.

Chau JK, Lin JR, Atashband S, et al. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope, 2010, 120(5):1011-1021.

Tsuzuki N, Wasano K. Idiopathic sudden sensorineural hearing loss: a review focused on the contribution of vascular pathologies. Auris Nasus Larynx, 2024, 51(4):747-754.

Khosravipour M, Rajati F. Sensorineural hearing loss and risk of stroke: a systematic review and meta-analysis. Sci Rep, 2021, 11(1):11021.

Simões J, Vlaminck S, Seiça RMF, et al. Cardiovascular risk and sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope, 2023, 133(1):15-24.

Merchant SN, Adams JC, Nadol JB Jr. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol, 2005, 26(2):151-160.

Formeister EJ, Wu MJ, Chari DA, et al. Assessment of sudden sensorineural hearing loss after COVID-19 vaccination. JAMA Otolaryngol Head Neck Surg, 2022, 148(4):307-315.

Frosolini A, Franz L, Daloiso A, et al. Digging into the role of inflammatory biomarkers in sudden sensorineural hearing loss diagnosis and prognosis. Medicina (Kaunas), 2022, 58(7):963.

Stancheva I. Sudden sensorineural hearing loss – an emergency in otorhinolaryngology. Practical guidance. MedInfo, 2026 (in press). [in Bulgarian]

Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am, 1975, 8(2):467-473.

Berrettini S, Seccia V, Fortunato S, et al. Analysis of the 3-dimensional fluid-attenuated inversion-recovery (3D-FLAIR) sequence in idiopathic sudden sensorineural hearing loss. JAMA Otolaryngol Head Neck Surg, 2013, 139(5):456-464.

Zongyi W, Shizhen Z, Danheng Z, Shuzhi Y, Mingfang D. The prognostic value of semicircular canal function testing in idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis. Front Neurol, 2026, 17:1796414.

Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke, 2009, 40(11):3504-3510.

Tarnutzer AA, Lee SU, Kim JS, Kaski D. The challenge of diagnosing labyrinthine stroke – a critical review. Brain Sci, 2025, 15(7):725.

Newman-Toker DE, Kerber KA, Hsieh YH, et al. HINTS outperforms ABCD2 to screen for stroke in acute continuous vertigo and dizziness. Acad Emerg Med, 2013, 20(10):986-996.

Sara SA, Teh BM, Friedland P. Bilateral sudden sensorineural hearing loss: review. J Laryngol Otol, 2014, 128(Suppl 1):S8-S15.

Bhat AM, Nanu DP, Nguyen SA, Meyer TA, Labadie RF. Prognosis of bilateral sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope, 2024. doi:10.1002/lary.31391.

Franz L, Gallo C, Marioni G, de Filippis C, Lovato A. Idiopathic sudden sensorineural hearing loss in children: a systematic review and meta-analysis. Otolaryngol Head Neck Surg, 2021, 165(2):244-254.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. S1-Leitlinie „Hörsturz (akuter idiopathischer sensorineuraler Hörverlust)“. AWMF-Reg.-Nr. 017/010 (withdrawn).

Plontke SK, Girndt M, Meisner C, et al. High-dose glucocorticoids for the treatment of sudden hearing loss (HODOKORT). NEJM Evid, 2024, 3(1):EVIDoa2300172.

Plontke SK. Die HODOKORT-Studie und aktuelle Aspekte der Hörsturztherapie mit Glukokortikoiden. HNO, 2024. doi:10.1007/s00106-024-01458-3.

Herrera M, García Berrocal JR, García Arumí A, Lavilla MJ, Plaza G. Update on consensus on diagnosis and treatment of idiopathic sudden sensorineural hearing loss. Acta Otorrinolaringol Esp, 2019, 70(5):290-300.

Marx M, Younes E, Chandrasekhar SS, et al. International consensus (ICON) on treatment of sudden sensorineural hearing loss. Eur Ann Otorhinolaryngol Head Neck Dis, 2018, 135(1S):S23-S28.

Joshua TG, Ayub A, Wijesinghe P, Nunez DA. Hyperbaric oxygen therapy for patients with sudden sensorineural hearing loss: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg, 2022, 148(1):5-11.

Agarwal L, Pothier DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev, 2009, (4):CD003422.

Wang M, Liu Y, Du Z, Zhu X, Luo G. [A systematic review of vasodilators for sudden sensorineural hearing loss]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2010, 24(19):869-871. Chinese.

Kurioka T, Sano H, Furuki S, Yamashita T. Long-term administration of vitamin B12 and adenosine triphosphate for idiopathic sudden sensorineural hearing loss: a retrospective study. PeerJ, 2020, 8:e10406.

Kitoh R, Nishio SY, Sato H, et al. Clinical practice guidelines for the diagnosis and management of acute sensorineural hearing loss. Auris Nasus Larynx, 2024, 51(4):811-821.

Yang CH, Ko MT, Peng JP, Hwang CF. Zinc in the treatment of idiopathic sudden sensorineural hearing loss. Laryngoscope, 2011, 121(3):617-621.

Burschka MA, Hassan HA, Reineke T, et al. Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients. Eur Arch Otorhinolaryngol, 2001, 258(5):213-219.

Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D. Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol, 2003, 24(4):572-575.

Yue WL, Li P, Qi PY, Li HJ, Zhou H. Role of low-molecular-weight heparins in the treatment of sudden hearing loss. Am J Otolaryngol, 2003, 24(5):328-333.

Kim J, Jeong J, Ha R, Sunwoo W. Heparin therapy as adjuvant treatment for profound idiopathic sudden sensorineural hearing loss. Laryngoscope, 2020, 130:1310-1315.

Rauch SD, Halpin CF, Antonelli PJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA, 2011, 305(20):2071-2079.

Plontke SK, Meisner C, Agrawal S, et al. Intratympanic corticosteroids for sudden sensorineural hearing loss. Cochrane Database Syst Rev, 2022, 7(7):CD008080.

Wei BP, Stathopoulos D, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev, 2013, (7):CD003998.

Smith ME, Knappett R, Vickers D, et al. Protocol for a multicentre randomised controlled trial of steroid administration routes for idiopathic sudden sensorineural hearing loss: the STARFISH trial. PLoS One, 2024, 19(2):e0290480.

Tobar Palacios C, Pulido González LV, Gómez Triana LV, et al. Beyond steroid monotherapy: a systematic review and meta-analysis of combination therapy for severe to profound sudden sensorineural hearing loss. Braz J Otorhinolaryngol, 2026, 92(5):101849.

Rommelspacher H, Bera S, Brommer B, et al. A single dose of AC102 restores hearing in a guinea pig model of noise-induced hearing loss to almost prenoise levels. Proc Natl Acad Sci U S A, 2024, 121(15):e2314763121.

Staecker H, Jokovic G, Karpishchenko S, et al. Efficacy and safety of AM-111 in the treatment of acute unilateral sudden deafness – a double-blind, randomized, placebo-controlled phase 3 study. Otol Neurotol, 2019, 40(5):584-594.

Chaushu H, Ungar OJ, Abu Eta R, et al. Spontaneous recovery rate of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis. Clin Otolaryngol, 2023, 48(3):395-402.

Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 2020, 396(10248):413-446.

Snapp HA, Holt FD, Liu X, Rajguru SM. Comparison of speech-in-noise and localization benefits in unilateral hearing loss subjects using contralateral routing of signal hearing aids or bone-anchored implants. Otol Neurotol, 2017, 38(1):11-18.

Idriss SA, Reynard P, Marx M, et al. Short- and long-term effect of cochlear implantation on disabling tinnitus in single-sided deafness patients: a systematic review. J Clin Med, 2022, 11(19):5664.




DOI: http://dx.doi.org/10.14748/orl.v22i3.10931

Refbacks

Font Size


|